Banks expect Novo to raise guidance on 4 November, helped by the Wegovy pill
J.P. Morgan analysts expect Novo Nordisk to lift its full-year sales and operating profit outlook when it reports third-quarter results on 4 November, citing strong demand for the Wegovy pill. Lilly reports its own Q3 numbers on 29 October.
Source: MedWatch (22 Oct 2026).